Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs

BACKGROUND: Identifying populations that benefit from immune checkpoint blockade (ICB) therapy remains a major challenge in the treatment of lung adenocarcinoma (LUAD). Existing programmed cell death (PCD) related prognostic models only consider a single mechanism, such as ferroptosis, necroptosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lei, Ji, Jingbin, Zhang, Chenyu, Wu, Zhe, Sun, Yuhui, Fan, Kun, Du, Wenxing, Liu, Ao, Jiao, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641322/
https://www.ncbi.nlm.nih.gov/pubmed/36389299
http://dx.doi.org/10.21037/jtd-22-1151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641322/
https://www.ncbi.nlm.nih.gov/pubmed/36389299
http://dx.doi.org/10.21037/jtd-22-1151

Ejemplares similares